Larsen P.R., Davies T.F., Hay I.D. (1998) The thyroid gland. Williams' textbook of endocrinology, 9th Edition , Wilson JD, Foster DW, Kronenberg HM, Larsen PR (Eds). WB Saunders Company, Philadelphia; 389-515.
Wadeleux P., Winand-Delvigne J., Ruf J., Carayon P., Winand R. (1989) Cytotoxic assay of circulating thyroid peroxydase antibodies. Autoimmunity 4:247-254.
Phillips D., Prentice L., Upadhyaya M. (1991) Autosomal dominant inheritance of autoantibodies to thyroid peroxydase and thyroglobulin: Studies in families non selected for autoimmune thyroid disease. J Clin Endocrinol Metab 72:973-975.
Stagnaro-Green A., Roman S.H., Cobin R.H. (1992) A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: Evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 74:645-653.
Stagnaro-Green A., Roman S.H., Cobin R.H. (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264:1422-1426.
Paschke R., Van Sande J., Parma J., Vassart G. (1996) The TSH receptor and thyroid diseases. Baillière's Clin Endocrinol Metab 10:9-27.
Kraiem Z., Lahat N., Glaser B. (1987) Thyrotropin receptor blocking antibodies: Incidence, characterization and in-vitro synthesis. Clin Endocrinol 27:409-421.
Costagliola S., Morgenthaler N.G., Hoermann R. (1999) Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves'disease. J Clin Endocrinol Metab 84:90-97.
Costagliola S., Many M.C., Denef J.F. (2000) Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest 105:803-811.
Martin A., Nakashima M., Zhou A. (1997) Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease. J Clin Endocrinol Metab 82:3361-3366.
Paschke R., Geenen V. (1995) Messenger RNA expression for a TSH receptor variant in the thymus of a two-year child. J Mol Med 73:577-580.
Dutton C.M., Joba W., Spitzweg C. (1997) Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid 7:879-884.
Spitzweg C., Joba W., Heufelder A.E. (1999) Expression of thyroid-related genes in human thymus. Thyroid 9:133-141.
Murakami M., Hosoi Y., Negishi T. (1996) Thymic hyperplasia in patients with Graves'disease. Identification of thyrotropin receptors in human thymus. J Clin Invest 98:2228-2234.
Weetman A.P. (2000) Graves' disease. N Engl J Med 343:1236-1248.
Chiovato L., Pinchera L. (1996) Stressful life events and Graves'disease. Eur J Endocrinol 134:680-682.
Bartalena L., Bogazzi F., Tanda M.L. (1995) Cigarette smoking and the thyroid. Eur J Endocrinol 133:507-512.
Gilquin J., Viard J.-P., Jubault V. (1999) Delayed occurrence of Graves' disease after immune restoration with HAART: Highly active antiretroviral therapy. Lancet 354:1691-1695.
Bahn R.S., Dutton C.M., Natt N. (1998) Thyrotropin receptor expression in Graves' orbital adipose/connective tissue: Potential autoantigen in Graves' ophtalmopathy. J Clin Endocrinol Metab 83:998-1002.
Weetman A.P., DeGroot L. (1999) Autoimmunity to the thyroid gland. Thyroid disease manager, Chicago: Endocrine Education; . http://www.thyroidmanager.org
Mozes E., Zinger H., Kohn L.D., Singer D.S. (1998) Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole. J Clin Immunol 18:106-113.
Hashizume K., Ishikawa K., Sakurai A. (1996) Administration of thyroxine in treated Graves' disease: Effects on the level of antibodies to thyroid stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 334:220-224.
Farrar J.J., Toft A.D. (1995) Iodine-131 treatment of hyperthyroidism: Current issues. Clin Endocrinol 43:325-329.
Imseis R.E., Vanmiddlesworth L., Massie J.D. (1998) Pre-treatment with propylthiouracil but not methimazole reduces the therapeutic efficiency of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83:685-687.
Miccoli P., Vitti P., Rago T. (1996) Surgical treatment of Graves' disease: Subtotal or total thyroidectomy?. Surgery 120:1020-1025.
Winand R., Cornet G., Etienne-Decerf J. (1988) Le traitement de l'exophtalmie endocrinienne. Rev Méd Liège 43:385-388.
Glinoer D., Etienne-Decerf J., Schrooyen M. (1986) Beneficial effects of intensive plasma exchange followed by immunosuppresive therapy in severe Graves' ophtalmopathy. Acta Endocrinol (Copenh) 111:30-38.
Bartalena L., Pinchera A., Marcocci M. (2000) Management of Graves' ophtalmopathy: Reality and perspectives. Endocr Rev 21:168-199.
Ferone D., Van Hagen P.M., Van Koetsveld P.M. (1999) In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells. Endocrinology 140:373-380.
Krassas G.E., Dumas A., Pontikides N. (1995) Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol 42:571-580.
Kung A.W.C., Jones B.M. (1998) A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. J Clin Endocrinol Metab 83:514-518.
Laurberg P., Nygaard B., Glinoer D. (1998) Guidelines for TSH-receptor antibody measurements in pregnancy: Results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 139:584-586.
Glinoer D. (1998) The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends Endocrinol Metab 9:403-411.
